Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2023 Jun 2;14:1226814. doi: 10.3389/fimmu.2023.1226814

Corrigendum: Do common infections trigger disease-onset or -severity in CTLA-4 insufficiency?

Máté Krausz 1,2,3,4,, Noriko Mitsuiki 2,, Valeria Falcone 5, Johanna Komp 6, Sara Posadas-Cantera 1,2,6, Hanns-Martin Lorenz 7, Jiri Litzman 8, Daniel Wolff 9, Maria Kanariou 10, Anita Heinkele 11, Carsten Speckmann 1,2,12, Georg Häcker 6, Hartmut Hengel 5, Laura Gámez-Díaz 1,2, Bodo Grimbacher 1,2,3,13,14,15,*
PMCID: PMC10273397  PMID: 37334381

In the published article, there was an error in the Funding statement. The following funding information is missing: “We acknowledge support by the Open Access Publication Fund of the University of Freiburg.” The correct Funding statement appears below.

Funding Statement

This work was supported by the Deutsche Forsch-ungsgemeinschaft (DFG) IMPATH SFB1160/2_B5. BG receives support by the Deutsche Forschungsgemeinschaft (DFG) SFB1160/2_B5, under Germany’s Excellence Strategy (CIBSS – EXC-2189 – Project ID 390939984, and RESIST – EXC 2155 – Project ID 390874280); by the E-rare program of the EU, managed by the DFG, grant code GR1617/14-1/iPAD; and by the German Federal Ministry of Education and Research (BMBF) through a grant to the German Auto-Immunity Network (GAIN), grant code 01GM1910A. HH is funded by the Deutsche Forschungsgemeinschaft (DFG) through HE2526/9-1. MK is supported by the Deutsche Forschungsgemeinschaft (DFG) SFB1160_2 as clinician scientist associated to IMM-PACT-Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany. We acknowledge support by the Open Access Publication Fund of the University of Freiburg.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES